
Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
Join us for a virtual press conference to discuss the FDA's draft recommendations to eliminate time-based deferrals for certain populations at increased risk of HIV and instead to assess blood donor eligibility using gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV.
Virtual Press Conference: Blood Donation Guidance – 1/27/2023FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
The FDA’s multipronged response to monkeypox (mpox) includes efforts in the areas of diagnostics, vaccines and therapeutics.
FDA works closely with manufacturers to prevent or reduce the impact of drug shortages.
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Jan 26
Food & Beverages
Jan 25
Food & Beverages
Jan 25
Food & Beverages
In 2022, CDER approved 37 new drugs never before approved or marketed in the U.S., known as “novel” drugs.
LMAP lays out our plans to strengthen our technology leadership capabilities to drive change at the business, technology, data, and cybersecurity levels.
CMAP will leverage Artificial Intelligence and Machine Learning technologies to enhance cyber detection and response capabilities.
Jan 30
Animal & Veterinary
Jan 27
Biologics
Jan 24
Food & Beverages